HNRNPA2B1 and osteosarcoma: On the other hand, the finding regarding HNRNPA2B1 is contrary to other studies where high expression of HNRNPA2B1 was significantly associated with poor prognosis in osteosarcoma (38), esophageal cancer (39) and adrenocortical carcinoma (40).